Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance

Arthritis and Rheumatism

Volumn 44, Issue 8, 2001, Pages 1917-1927

  Derry, Catherine J ^a   Harper, Nicola ^a   Huw Davies, D ^a   Murphy, John J ^a   Staines, Norman A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN TYPE 2; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; CLONAL ANERGY; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG TOLERANCE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; ARTHRITIS; B-LYMPHOCYTES; CELLS, CULTURED; COLLAGEN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; T-LYMPHOCYTES;

EID: 0034892140     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200108)44:8<1917::AID-ART330>3.0.CO;2-W     Document Type: Article

References (63)

1. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats
2. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen
3. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen
4. Prevention of pristane-induced arthritis by the oral administration of type II collagen
5. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis
6. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope
7. Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein
8. Suppression of murine collagen-induced arthritis by nasal administration of collagen
9. Intranasal administration of denatured type II collagen and its fragments can delay the onset of collagen-induced arthritis
10. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice: Amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis
11. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis
12. Mucosal tolerance: A two-edged sword to prevent and treat autoimmune diseases
13. T cell immunity to oral allergens
14. Oral tolerance: Mechanisms and therapeutic applications
15. Oral type II collagen treatment in early rheumatoid arthritis: A double-blind, placebo-controlled, randomized trial
16. Type II collagen serology: A guide to clinical responsiveness to oral tolerance?
17. Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial
18. Control of rheumatoid arthritis by oral tolerance
19. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
20. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis
21. Suppression of collagen induced arthritis by oral administration of type II collagen: Changes in immune and arthritic responses mediated by active peripheral suppression
22. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
23. Cellular mRNA expression of interferon-gamma (IFN-γ), IL-4 and transforming growth factor-beta (TGF-β) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG)
24. Inactivation of Th1 and Th2 cells by feeding ovalbumin
25. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage
26. Clonal anergy is a potent mechanism of oral tolerance in the suppression of acute antigen-induced arthritis in rats by oral administration of the inducing antigen
27. Peripheral deletion of antigen-reactive T cells in oral tolerance
28. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis
29. Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice
30. Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin
31. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats
32. Dose-dependent induction of distinct anergic phenotypes: Multiple levels of T cell anergy
33. Arthritis: Animal models of oral tolerance
34. T cell response to orally administered antigens and its role in the treatment of autoimmune diseases
35. Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection
36. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity
37. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells
38. Induction of tolerance via the respiratory mucosa
39. Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis
40. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen
41. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis
42. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain
43. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen
44. Impaired lymphokine secretion in anergic CD4+ T cells leads to defective help for B cell growth and differentiation
45. Mucosal tolerance and arthritis
46. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
47. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis
48. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
49. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: A role for IL-10
50. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: Studies with OVA and human cartilage gp-39
51. Regulation of house dust mite responses by intranasally administered peptide: Transient activation of CD4+ cells precedes the development of tolerance in vivo
52. Antigen-specific T cell activation and proliferation during oral tolerance induction
53. Differences in epitopes recognized by T cells during oral tolerance and priming
54. Nasal tolerance to dominant and subdominant epitopes of collagen type II and protection against collagen-induced arthritis
55. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin
56. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis
57. Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide
58. Suppression of murine chronic relapsing experimental encephalomyelitis by the oral administration of myelin basic protein
59. The immunological basis of oral tolerance
60. Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization
61. Correlation between IgG anti-type II collagen levels and arthritic severity in murine arthritis
62. Collagen-induced arthritis in the rat: Modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum
63. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis